47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
82.99.Z - Other business support activities, not elsewhere classified
86.90.E - Healthcare
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,9 | 1,1 | 0,8 | -27,8 |
Gross profit (loss) | 1 | 1,2 | 0,9 | -22,4 |
EBITDA | 1 | 1,2 | 1,2 | -2,7 |
Short time liabilities | 2,3 | 2,3 | 3 | 31,9 |
Other operating costs | -0 | -0 | -0 | 29,9 |
Equity capital | 2,6 | 2,9 | 2,8 | -3 |
Operating profit (EBIT) | 1 | 1,2 | 0,9 | -22,1 |
Assets | 4,9 | 5,1 | 5,8 | 12,3 |
Net profit (loss) | 1 | 1,2 | 0,9 | -22,4 |
Cash | 0,4 | 0,4 | 0,4 | 20,4 |
Net income from sale | 13,6 | 14,5 | 15,7 | 8,3 |
Liabilities and provisions for liabilities | 2,3 | 2,3 | 3 | 31,9 |
Working assets | 4,5 | 4,8 | 5,1 | 8 |
Other income costs | 0,1 | 0,1 | 0,1 | 49,9 |
Depreciation | 0 | 0 | 0,2 | 11 886,3 |
% | % | % | p.p. | |
Profitability of capital | 38,7 | 41,3 | 33 | -8,3 |
Equity capital to total assets | 53,1 | 56,1 | 48,4 | -7,7 |
Gross profit margin | 7,4 | 8,2 | 5,9 | -2,3 |
EBITDA Margin | 7,4 | 8,2 | 7,4 | -0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 62 | 57 | 69 | 12 |
Current financial liquidity indicator | 1.9651875495910645 | 2.1070709228515625 | 1.7250704765319824 | -0,4 |
Net dept to EBITDA | -0.3766523599624634 | -0.3063487112522125 | -0.3792361915111542 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane